Skip to main navigation
Galectin Therapeutics Logo
  • Blog
  • What We Do
    • Galectin Proteins
    • Develop Proprietary Compounds
    • Discovery Programs
    • Intellectual Property
  • Our Pipeline
    • Pipeline Overview
    • Development Programs
  • About
    • About Us
    • Leadership
    • Board of Directors
    • Special Consultants
    • Careers
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
    • FAQs
    • Email Alert Subscription
  • Learn More
    • About Belapectin
    • About Galectin-3
    • About the NAVIGATE Study
    • Resources
    • Video Library
    • Publications
    • News
  • Contact Us
  • What We Do
    • Galectin Proteins
    • Develop Proprietary Compounds
    • Discovery Programs
    • Intellectual Property
  • Our Pipeline
    • Pipeline Overview
    • Development Programs
  • About
    • About Us
    • Leadership
    • Board of Directors
    • Special Consultants
    • Careers
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
    • FAQs
    • Email Alert Subscription
  • Learn More
    • About Belapectin
    • About Galectin-3
    • About the NAVIGATE Study
    • Resources
    • Video Library
    • Publications
    • News
  • Contact Us
Press Releases

Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • Special Consultants
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • Stock Information
    • Analyst Coverage
  • FAQs
  • Email Alert Subscription

Press Releases

Date Title and Summary View
Toggle SummaryFeb 03, 2009 PRO-PHARMACEUTICALS UPDATES RIGHTS OFFERING: FILES AMENDED REGISTRATION STATEMENT View HTML
PRO-PHARMACEUTICALS UPDATES RIGHTS OFFERING: FILES AMENDED REGISTRATION STATEMENT 16.6 KB

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 34
  • Page 35
  • Page 36
  • Current page 37
Galectin Therapeutics Logo - Footer

© 2023 Galectin Therapeutics Inc. – All Rights Reserved

  • Compassionate Use Policy
  • Privacy Policy
  • Terms of Use
  • Sitemap

Disclaimer: This site may contain forward-looking information.